View More Recent Stories
-
Alvotech (ALVO) Announces Positive Topline Results from Confirmatory Patient Study for AVT03, a Proposed Biosimilar for Prolia® and Xgeva
-
Alvotech (ALVO) Reports Prelim Q2 Results
-
Alvotech (ALVO) Receives Conversion Notices for Majority of Convertible Bonds
